Literature DB >> 29139010

Radiobiology and radiotherapy of brain metastases.

Anuradha Thiagarajan1, Yoshiya Yamada2.   

Abstract

Brain metastases are the most common intracranial tumors in adults, accounting for more than 50% of all such cases. The approach to and management of brain metastases have evolved significantly in recent years due to several reasons. These include advances in neurosurgical and radiotherapeutic techniques, improved systemic therapy options offering better systemic and intracranial disease control and prolongation of survival as a result of these improvements, making side-effects of proposed therapies (e.g. neurocognitive decline from whole brain radiotherapy) an important consideration. In this article, we review the the primary therapeutic approaches to the management of brain metastases, namely, surgery, stereotactic radiosurgery, and whole brain radiation therapy and the primary factors dictating choice.

Entities:  

Keywords:  Brain metastases; SRS; Stereotactic radiotherapy; WBRT; Whole brain radiotherapy

Mesh:

Year:  2017        PMID: 29139010     DOI: 10.1007/s10585-017-9865-7

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  30 in total

1.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  Recurrent brain metastases from lung cancer: the impact of reoperation.

Authors:  Munzir Al-Zabin; Winfried O Ullrich; Alexander Brawanski; Martin A Proescholdt
Journal:  Acta Neurochir (Wien)       Date:  2010-07-09       Impact factor: 2.216

3.  Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul D Brown; Stephanie Pugh; Nadia N Laack; Jeffrey S Wefel; Deepak Khuntia; Christina Meyers; Ali Choucair; Sherry Fox; John H Suh; David Roberge; Vivek Kavadi; Soren M Bentzen; Minesh P Mehta; Deborah Watkins-Bruner
Journal:  Neuro Oncol       Date:  2013-08-16       Impact factor: 12.300

4.  Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.

Authors:  John H Suh; Baldassarre Stea; Abdenour Nabid; John J Kresl; André Fortin; Jean-Philippe Mercier; Neil Senzer; Eric L Chang; Adam P Boyd; Pablo J Cagnoni; Edward Shaw
Journal:  J Clin Oncol       Date:  2005-11-28       Impact factor: 44.544

5.  Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.

Authors:  Christine Heisterkamp; Tiina Haatanen; Steven E Schild; Dirk Rades
Journal:  Strahlenther Onkol       Date:  2010-01-26       Impact factor: 3.621

6.  Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Authors:  Paul D Brown; Kurt Jaeckle; Karla V Ballman; Elana Farace; Jane H Cerhan; S Keith Anderson; Xiomara W Carrero; Fred G Barker; Richard Deming; Stuart H Burri; Cynthia Ménard; Caroline Chung; Volker W Stieber; Bruce E Pollock; Evanthia Galanis; Jan C Buckner; Anthony L Asher
Journal:  JAMA       Date:  2016-07-26       Impact factor: 56.272

7.  Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma.

Authors:  A Muacevic; F W Kreth; A Mack; J-C Tonn; B Wowra
Journal:  Minim Invasive Neurosurg       Date:  2004-08

8.  Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Authors:  Monica Garcia-Barros; Francois Paris; Carlos Cordon-Cardo; David Lyden; Shahin Rafii; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Science       Date:  2003-05-16       Impact factor: 47.728

9.  Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.

Authors:  Minesh P Mehta; Patrick Rodrigus; C H J Terhaard; Aroor Rao; John Suh; Wilson Roa; Luis Souhami; Andrea Bezjak; Mark Leibenhaut; Ritsuko Komaki; Christopher Schultz; Robert Timmerman; Walter Curran; Jennifer Smith; See-Chun Phan; Richard A Miller; Markus F Renschler
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544

10.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

View more
  7 in total

1.  Curing brain metastases.

Authors:  Rahul Jandial
Journal:  Clin Exp Metastasis       Date:  2017-10       Impact factor: 5.150

2.  Factors associated with long-term survival in central nervous system metastases.

Authors:  Bernardo Cacho-Díaz; Héctor Spínola-Maroño; Alberto González-Aguilar; Oscar Arrieta
Journal:  J Neurooncol       Date:  2018-07-12       Impact factor: 4.130

Review 3.  Ionizing Radiation as a Source of Oxidative Stress-The Protective Role of Melatonin and Vitamin D.

Authors:  Jarosław Nuszkiewicz; Alina Woźniak; Karolina Szewczyk-Golec
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

4.  The Effect of Hippocampal Avoidance Whole Brain Radiotherapy on the Preservation of Long-Term Neurocognitive Function in Non-Small Cell Lung Cancer Patients With Brain Metastasis.

Authors:  Buhai Wang; Shiwei Fu; Yuxiang Huang; Liqin Liu; Yichen Liang; Wenxian An; Yaqin Fan; Yisa Zhao
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

5.  Rodent Model of Brain Radionecrosis Using Clinical LINAC-Based Stereotactic Radiosurgery.

Authors:  Sean P Devan; Guozhen Luo; Xiaoyu Jiang; Jingping Xie; Daniel Dean; Levi S Johnson; Manuel Morales-Paliza; Hannah Harmsen; Junzhong Xu; Austin N Kirschner
Journal:  Adv Radiat Oncol       Date:  2022-07-19

6.  Long-term survival results after treatment for oligometastatic brain disease.

Authors:  Carsten Nieder; Mandy Hintz; Ilinca Popp; Angelika Bilger; Anca L Grosu
Journal:  Rep Pract Oncol Radiother       Date:  2020-03-04

7.  Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy.

Authors:  Ziad Maksoud; Manuel Alexander Schmidt; Yixing Huang; Sandra Rutzner; Sina Mansoorian; Thomas Weissmann; Christoph Bert; Luitpold Distel; Sabine Semrau; Sebastian Lettmaier; Ilker Eyüpoglu; Rainer Fietkau; Florian Putz
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.